Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €9.45, the stock trades at a trailing P/E ratio of 44.4x. Average forward P/E is 23x in the Personal Products industry in Italy. Total returns to shareholders of 6.4% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.99 per share. Reported Earnings • Mar 24
Full year 2022 earnings released Full year 2022 results: Revenue: €15.6m (up 23% from FY 2021). Net income: €342.3k (down 46% from FY 2021). Profit margin: 2.2% (down from 5.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 8.8% p.a. on average during the next 2 years, compared to a 7.7% growth forecast for the Personal Products industry in Italy. Valuation Update With 7 Day Price Move • Dec 08
Investor sentiment improved over the past week After last week's 19% share price gain to €8.40, the stock trades at a trailing P/E ratio of 58x. Average forward P/E is 21x in the Personal Products industry in Italy. Total loss to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €15.25 per share. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Chairman of the Board of Statutory Auditors Pierluigi Pipolo was the last director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 03
First half 2022 earnings released: EPS: €0 (vs €0.23 in 1H 2021) First half 2022 results: EPS: €0 (down from €0.23 in 1H 2021). Revenue: €6.90m (up 13% from 1H 2021). Net loss: €26.9k (down 107% from profit in 1H 2021). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in Italy. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Chairman of the Board of Statutory Auditors Pierluigi Pipolo was the last director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Price Target Changed • Apr 14
Price target increased to €13.45 Up from €12.38, the current price target is an average from 2 analysts. New target price is 60% above last closing price of €8.42. Stock is up 2.7% over the past year. Buying Opportunity • Apr 06
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 7.7%. The fair value is estimated to be €11.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Feb 04
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 6.1%. The fair value is estimated to be €11.72, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% per annum over the last 3 years. The company has become profitable over the last 3 years. Reported Earnings • Oct 01
First half 2021 earnings released The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €6.53m (up 110% from 1H 2020). Net income: €374.9k (up €502.6k from 1H 2020). Profit margin: 5.7% (up from net loss in 1H 2020). The move to profitability was driven by higher revenue. Valuation Update With 7 Day Price Move • Aug 26
Investor sentiment improved over the past week After last week's 26% share price gain to €10.30, the stock trades at a trailing P/E ratio of 26.3x. Average forward P/E is 32x in the Personal Products industry in Europe. Total returns to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €17.98 per share. Reported Earnings • Apr 01
Full year 2020 earnings released The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €9.52m (down 4.8% from FY 2019). Net income: €642.4k (up 8.6% from FY 2019). Profit margin: 6.7% (up from 5.9% in FY 2019). The increase in margin was driven by lower expenses. Is New 90 Day High Low • Jan 11
New 90-day high: €8.52 The company is up 2.0% from its price of €8.36 on 13 October 2020. The Italian market is up 14% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.98 per share. Is New 90 Day High Low • Dec 18
New 90-day low: €7.96 The company is down 8.0% from its price of €8.64 on 18 September 2020. The Italian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €22.27 per share. Is New 90 Day High Low • Oct 30
New 90-day low: €8.00 The company is down 7.0% from its price of €8.60 on 31 July 2020. The Italian market is down 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Personal Products industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €19.68 per share. Price Target Changed • Oct 17
Price target lowered to €11.69 Down from €13.05, the current price target is an average from 2 analysts. The new target price is 40% above the current share price of €8.34. As of last close, the stock is down 18% over the past year. Is New 90 Day High Low • Oct 13
New 90-day low: €8.36 The company is down 5.0% from its price of €8.76 on 15 July 2020. The Italian market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.65 per share. お知らせ • Jul 31
An undisclosed buyer acquired 12.2% stake in Kolinpharma S.p.A. (BIT:KIP) from Rita Paola Petrelli. An undisclosed buyer acquired 12.2% stake in Kolinpharma S.p.A. (BIT:KIP) from Rita Paola Petrelli on April 22, 2020. Pursuant to the terms of the transaction, Rita Paola Petrelli sold 0.2 million Kolinpharma shares. As a result of the transaction, stake of Rita Paola Petrelli has decreased from 71.82% to 59.62%.
An undisclosed buyer completed the acquisition of 12.2% stake in Kolinpharma S.p.A. (BIT:KIP) from Rita Paola Petrelli on April 22, 2020.